We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 860 results
  1. Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis

    Background

    Cutaneous adverse drug reactions (cADRs) are one of the most common, severe, and life-threatening types of adverse reactions following...

    Israa Alfares, Muhammad Shahid Javaid, ... Patrick Kwan in CNS Drugs
    Article 12 February 2021
  2. Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review

    Background

    Tardive dyskinesia (TD) is a persisting, and potentially irreversible, movement disorder associated with treatment with dopamine receptor...

    Frank M. C. Besag, Michael J. Vasey, ... Chris Hollis in Drug Safety
    Article 11 June 2024
  3. Effect of Enzyme-Inducing Antiseizure Medications on the Risk of Sub-Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study

    Background

    Stroke and thromboembolic events occurring among patients taking direct oral anticoagulants (DOACs) have been associated with low...

    Amichai Perlman, Rachel Goldstein, ... Mordechai Muszkat in CNS Drugs
    Article Open access 17 February 2021
  4. Psychiatric implications of anti-seizure medications in epileptic population

    Background and objective

    Epilepsy is a prevalent neurological disorder that affects a significant number of individuals globally. This condition is...

    Bushra Khalid, Zaid Waqar, ... Zeeshan Munawar in BMC Neurology
    Article Open access 21 May 2024
  5. Levetiracetam versus Phenobarbitone for Management of Neonatal Seizures: A Systematic Review and Meta-analysis

    Objectives

    To review whether levetiracetam is non-inferior to phenobarbitone as the first-choice antiseizure medication (ASM).

    Methods

    The authors...

    Jogender Kumar, Bharti Yadav, ... Jitendra Kumar Sahu in Indian Journal of Pediatrics
    Article 08 November 2023
  6. When Drugs Do Not Work: Alternatives to Antiseizure Medications

    Purpose of Review

    Despite the increase in the number of novel antiseizure medications over the past 20 years, approximately one-third of patients will...

    Sara Dawit, Amy Z. Crepeau in Current Neurology and Neuroscience Reports
    Article 09 July 2020
  7. Ketamine reduces seizure and interictal continuum activity in refractory status epilepticus: a multicenter in-person and teleneurocritical care study

    Background

    There is not a preferred medication for treating refractory status epilepticus (RSE) and intravenous ketamine is increasingly used....

    Brittany Harnicher, Nick M. Murray, ... Gabriel V. Fontaine in Neurological Sciences
    Article 11 June 2024
  8. Assessment of serum complement level in a sample of patients of idiopathic childhood epilepsy

    Background

    The etiology of epilepsy is still unknown in over a third of cases and a third of patients have seizures resistant to current antiseizure...

    Fatema Amr Adel, Nahed Salah El Deen Ahmed, ... Mona Mokhtar Wahid El Din in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 26 April 2024
  9. The impact of parent treatment preference and other factors on recruitment: lessons learned from a paediatric epilepsy randomised controlled trial

    Background

    In paediatric epilepsy, the evidence of effectiveness of antiseizure treatment is inconclusive for some types of epilepsy. As with other...

    Bernie Carter, Lucy Bray, ... Deb Pal in Trials
    Article Open access 06 February 2023
  10. An Update on Stiripentol Mechanisms of Action: A Narrative Review

    Stiripentol (Diacomit ® ) (STP) is an orally active antiseizure medication (ASM) indicated as adjunctive therapy, for the treatment of seizures...

    Alexandre Bacq, Antoine Depaulis, ... Marc Verleye in Advances in Therapy
    Article Open access 05 March 2024
  11. New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System

    γ-Aminobutyric acid (GABA) is the most prevalent inhibitory neurotransmitter in the mammalian brain and has been found to play an important role in...

    Emilio Perucca, Meir Bialer, H. Steve White in CNS Drugs
    Article Open access 21 August 2023
  12. COVID-19 vaccination uptake in children with epilepsy and vaccine hesitancy among their parents: a survey

    This study explored the coronavirus disease 2019 (COVID-19) vaccination coverage among children with epilepsy (CwE), factors affecting vaccination...

    Dandan Lou, Ye Song, ... Lin Yang in European Journal of Pediatrics
    Article 01 April 2024
  13. Association between anti-seizure medication and outcomes in infants

    Objective

    To compare treatment failure between: (1) infants treated with phenobarbital versus levetiracetam for first-line treatment and (2) infants...

    Elizabeth K. Sewell, Shannon E. G. Hamrick, ... Kaashif A. Ahmad in Journal of Perinatology
    Article 20 October 2021
  14. Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study

    Background and Objective

    Most second and third generation antiseizure medications (ASMs) are associated with cognitive adverse events, which are a...

    Pedro J Serrano-Castro, Teresa Ramírez-García, ... Juan De La Parra in CNS Drugs
    Article Open access 24 January 2024
  15. Seizures and epilepsy in patients with ischaemic stroke

    Background

    With the increased efficacy of stroke treatments, diagnosis and specific treatment needs of patients with post-stroke seizures (PSS) and...

    Johann Philipp Zöllner, Friedhelm C. Schmitt, ... Hermann Stefan in Neurological Research and Practice
    Article Open access 06 December 2021
  16. Driving eligibility following acute symptomatic seizure with structural brain lesion – English Version

    Acute symptomatic seizures are often caused by acute structural brain lesions. However, German guidelines for driving eligibility do not cover this...

    Martin Holtkamp, Eva Breuer, ... Bernd Vorderwülbecke in Zeitschrift für Epileptologie
    Article 04 November 2022
  17. Pediatric Status Epilepticus: Treat Early and Avoid Delays

    Pediatric convulsive status epilepticus (cSE) is a neurologic emergency with potential for morbidity and mortality. Rapid treatment and escalation of...

    Lindsey A. Morgan, Jennifer B. Hrachovec, Howard P. Goodkin in Pediatric Drugs
    Article 13 May 2023
  18. Care of Children with Infantile Epileptic Spasms Syndrome and Applicability of Telemedicine Amidst the COVID-19 Pandemic

    This ambispective, observational study evaluated the impact of the COVID-19 pandemic on managing children with Infantile epileptic spasms syndrome...

    Dev Desai, Priyanka Madaan, ... Jitendra Kumar Sahu in Indian Journal of Pediatrics
    Article 14 July 2023
  19. Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus

    Introduction

    Experts agree that there is a need for protocols to guide health professionals on how to best manage psychiatric comorbidities in...

    Vicente Villanueva, Jesús Artal, ... Julio Bobes in Neurology and Therapy
    Article Open access 24 January 2023
Did you find what you were looking for? Share feedback.